The spinal column is the most frequent site of bone metastasis. 1, 44 Metastatic spinal disease is a significant problem for a large number of patients: spinal metastases develop in between 5 and 10% of all patients with cancer during the course of their disease. 7 Approximately 40% of persons dying of cancer have autopsy evidence of spinal metastases; 2,7,28 10% of these will experience spinal cord compression with subsequent neurological deficits. 47, 55 The annual incidence of spinal cord compression due to spinal metastases is estimated to be 20,000 cases.
of magnetic resonance imaging, may increase the number of patients evaluated and metastatic lesions detected. Progress in many multimodality cancer treatments will prolong patient survival, resulting in more spinal metastases. Screening programs yielding earlier detection of malignant primary lesions will lead to identification of an ever-increasing number of spinal metastases.
Standard treatments for metastatic spinal tumors include radiotherapy alone, radiotherapy plus systemic chemotherapy, hormone therapy, surgical decompression followed by radiotherapy, and, more recently, extracranial radiosurgery. 21, 46 When a metastatic spinal tumor causes compression of the spinal cord or other neural elements, surgical decompression is often chosen. Based on the extent of spinal column destruction and the resulting biomechanical instability of the spine, fixation may be elected. The goal of local radiation therapy in the treatment of spinal metastases has been palliation of painful symptoms, prevention of pathological fractures of the vertebral body, and halting or reversing progression of neurological compromise. The role of radiosurgery has yet to be defined but will likely be limited to treatment of focal disease or use as a supplement to fractionated radiotherapy.
In this evidence-based review we will examine the basis for current clinical practice, focusing on the role of surgery in the management of metastatic spinal column disease.
Rationale for the Study
Metastatic spinal column tumors occur with sufficient frequency to warrant review. The role of surgery in the therapeutic management of vertebral column metastatic disease remains controversial. In 1998, the Canadian Task Force on the Periodic Health Examination produced an evidence-based guideline review of the literature. 33 At the time, the authors concluded that very few papers of high methodological quality had been published, and that more studies were needed to verify the validity of many of the clinical decisions regarding the management of this disease process.
For this review, medical literature addressing surgical management of vertebral column metastatic lesions was examined using the methods of evidence-based medicine to address the following question: "What is the role of surgical management of vertebral column metastatic disease?"
SEARCH METHODS
The database of the National Library of Medicine was searched using the PubMed search engine. The key words "spine" and "metastasis" were used, with limiting factors of "human" and "English language." All articles dating from 1964 through August 2003 were included in the final review; this search produced 1178 articles. Titles and abstracts were then reviewed, and only articles addressing surgical management of spinal metastases were retained. Papers that primarily analyzed the nonoperative treatment of spinal metastases were excluded in the evidentiary table. The bibliographies of included papers were also examined to assess the completeness of the literature review. Additional papers identified from these bibliographies that contained relevant supporting information were then included. This yielded a total of 46 articles, which are summarized in Table 1 . Additionally, we were aware of an abstract presented at the 39 th Annual Meeting of the American Society of Clinical Oncology by Patchell, et al. 40 Although this cannot be included in the evidentiary tables until it is published, it is noted in the Discussion and References sections.
Scientific Foundation
The annual incidence of spinal cord compression caused by spinal metastases is estimated to be 20,000 cases. 16 As discussed, the incidence of metastatic spinal disease is likely to increase in the future. In one evidencebased guideline review of the literature, researchers found that current surgical recommendations are based on inconclusive evidence. 33 Surgery may be considered a first-line treatment for ambulatory patients presenting with spinal instability, bone compression, or paraplegia. Our review focuses on the most significant articles identified in the literature search. The author and year of publication, a description of the study, a data class, and a conclusion is provided for each paper in Table 1 .
Classification of Evidence
When assessing the value of therapies or interventions, the available data are classified into one of three categories according to the criteria established in the guidelines for the management of acute cervical spine and spinal cord injuries. 4 
RESULTS
Currently, there is only one Class I study available in the peer-reviewed literature. 69 This study shows no significant outcome difference when comparing 16 patients who underwent laminectomy followed by radiation with 13 patients who underwent radiation alone. This study was performed in 1980, however, had a small population (29 patients), and a short mean follow-up duration (4 months). As mentioned previously, Patchell, et al., 40 recently performed a prospective randomized trial in 101 patients with spinal cord compression caused by metastasis. These authors showed that patients treated with surgery followed by radiotherapy maintained continence and had functional Frankel and American Spinal Injury Association Scale scores significantly longer than patients who were treated with radiotherapy alone. Also, a significantly larger number of non-ambulatory patients in the surgery group (56%) than in the radiotherapy group (19%) regained the ability to walk.
Four Class II studies have been published. 51, 55, 59, 62 In two of these studies the authors have proposed treatment algorithms. 51, 59 Wai and colleagues 62 used the Edmonton Symptom Assessment Scale both pre-and postoperatively in 25 consecutive patients who underwent surgery for spinal metastases. This study, as well as several Class III studies, 13, 14, 19, 24, 26, 48, 63, 64 indicated an improved quality of life in patients who had undergone surgery for spinal metastases.
Several studies showed that the majority of patients who underwent surgical decompression for spinal me-tastasis maintained ambulation. 6 17 found improvement in five of 11 patients presenting with paraplegia. In two studies, 34, 52 bladder continence improved in patients who underwent surgery.
In terms of survival, Sorensen, et al., 53 showed that patients who underwent laminectomy followed by radiotherapy attained a longer survival duration; however, this may have reflected a milder stage of disease in these patients, which would improve the potential for survival. Chataigner and Onimus 3 and Akeyson and McCutcheon 14 showed that although pain and neurological function improved in patients who underwent surgery, survival did not change. At the time of this retrospective review, 93 of 107 patients were dead. Radiation treatment alone was advocated as a first-line therapy for patients with highly or moderately radiosensitive tumors 50 and in those who were ambulatory; 58 although Tang, et al., showed that patients who underwent laminectomy followed by radiotherapy attained better results than those who underwent radiotherapy alone.
Outcome improved for patients who underwent surgery prior to radiation. 6, 22, 38, 57 Preoperative radiation increased the risk of wound complications and infection in two studies. 22, 57 Ghogawala, et al., found that the major wound complication rate was 32% in patients who underwent surgery after radiation, compared with 12% in patients in whom de novo surgery was performed. Sundaresan, et al., also found a 25% incidence of wound breakdown (10 of 40) in patients with prior radiation therapy compared with one wound infection in 40 in patients who underwent de novo surgery. One Class III study showed that the risk of major complications was significant, 64 and McDonnell, et al., 35 showed a major complication rate of 21% in patients who underwent anterior decompression and fusion; the majority of complications were related to pulmonary issues.
Several different approaches were used to ensure longterm stability for fusion, including the Wellesley wedge, 49 anterior cervical plating, 13 and anterior corpectomy. 17 Surgical decompression improved pain 3, 5, 17, 20, 24, 26, 27, 29, 30, 34, 38, 41, 52, 61, 63 and the quality of life 13, 14, 24, 63, 64 in several studies. Nevertheless, three studies indicated that the patients' longevity should be taken into account when determining the indications for surgery. 37, 43, 66 
DISCUSSION

Directions for Future Research
Prospective, randomized clinical trials are needed to compare the outcome in patients treated with surgical intervention with the outcome in patients receiving radiotherapy as a first-line treatment. Additional large-cohort studies would add Class II evidence that would be valuable in assessing the role of surgical intervention. Other areas of interest include surgical methods, extent of tumor resection, and the role of multimodality therapies.
Treatment Recommendations
Standards. There is insufficient evidence to recommend a treatment standard.
Guidelines. Surgical decompression and stabilization in the face of spinal instability is recommended for patients who experience progressive neurological deficits without complete paraplegia, bowel or bladder dysfunction, or significant pain. The goal of surgical intervention should be to improve pain and/or the quality of life and may have no effect on the survival rate. We recommend that surgical decompression and fusion be considered with caution for patients who present with complete paraplegia, unless these procedures are required for diagnostic purposes.
Options. Radiotherapy should be considered as a treatment option for patients who present with complete paraplegia or paralysis related to spinal metastatic disease. Radiotherapy may also be considered as a treatment option for patients who are ambulatory, with minimal neurological deficit or pain, especially in patients who harbor a known, radiosensitive tumor. Patients who experience progressive neurological deficits despite receiving radiotherapy should be considered candidates for urgent surgical decompression and/or stabilization.
CONCLUSIONS
Surgical intervention for metastatic spinal disease is beneficial in that it alleviates pain caused by metastases and improves the patient's quality of life. Nonetheless, there has been insufficient evidence to show that surgical intervention will improve survival duration. Surgical decompression and fusion have been shown by a number of methods and approaches to produce spinal stability and maintain it for the remainder of the patient's life. Patients presenting with significant neurological deficits may experience marked improvement after surgical decompression and fusion, assuming that the individual does not present with complete paraplegia. There has been insufficient evidence to recommend surgical intervention routinely in patients who present with complete paraplegia. Radiotherapy without surgical intervention should be reserved for the following categories of patients: 1) those who have known, radiosensitive tumors; 2) those who have little or no pain or neurological deficit; or 3) as a palliative therapy in patients who present with paraplegia.
